Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

4.10p
   
  • Change Today:
      0.23p
  • 52 Week High: 13.75
  • 52 Week Low: 1.45
  • Currency: UK Pounds
  • Shares Issued: 543.14m
  • Volume: 29,043,463
  • Market Cap: £22.27m
  • RiskGrade: 747

Genedrive Overview

Genedrive is in the health care sector and is currently trading at 4.10p per share. In the last year Genedrive 's share price has ranged from 1.45p to 13.75p.

1 Day Chart (26-07-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -9498.2% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 382.7 n/a
Pr/Book 10.3  
Latest F'cast
Revenue 12.2% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Genedrive Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-19 2.36 (4.52) (13.87)p n/a n/a n/a n/a 0.0%
30-Jun-20 1.06 (20.38) (54.48)p n/a n/a n/a n/a 0.0%
30-Jun-21 0.69 (1.85) (1.19)p n/a n/a n/a n/a 0.0%
30-Jun-22 0.05 (5.63) 5.50p 3.2 n/a n/a n/a 0.0%
30-Jun-23 0.06 (5.98) (5.50)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Genedrive Company Announcements

Breakthrough Device Designation from the U.S. FDA 15-Jul-2024 07:00 RNS
Short extension to NICE publication date 27-Jun-2024 09:28 RNS
Holding(s) in Company 25-Jun-2024 07:00 RNS

Genedrive ShareCast News

Genedrive test ordered by five Manchester area h... 24-May-2024 ShareCast
Genedrive shares jump on NICE test recommendation 03-Apr-2024 ShareCast
Genedrive receives R&D tax credit, plans fundraise 15-Mar-2024 ShareCast

Latest Genedrive Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Genedrive Market Data

Currency UK Pounds
Share Price 4.10p
Change Today 0.23p
% Change 5.81 %
52 Week High 13.75
52 Week Low 1.45
Volume 29,043,463
Shares Issued 543.14m
Market Cap £22.27m
RiskGrade 747

Genedrive Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
52.89% below the market average52.89% below the market average52.89% below the market average52.89% below the market average52.89% below the market average
48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average
Price Trend
90.95% below the market average90.95% below the market average90.95% below the market average90.95% below the market average90.95% below the market average
89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average89.19% below the sector average
Income Not Available
Growth
42.84% below the market average42.84% below the market average42.84% below the market average42.84% below the market average42.84% below the market average
54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average

Genedrive Dividends

No dividends found

Trades for 26-Jul-2024

Time Volume / Share Price
16:29 5,000 @ 4.07p
16:29 4,227 @ 4.14p
16:29 8,840 @ 4.14p
16:29 122,455 @ 4.09p
16:28 18,459 @ 4.09p

Genedrive Key Personnel

CFO Russell Shaw
CEO James Cheek

Top of Page